SCYX
SCYNEXIS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.66
−0.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.54x
- Price / sales
- 1.90x
- Price / cash flow
- -2.74x
Enterprise value
- Enterprise value
- -$15.7M
- EV / sales
- -0.82x
- EV / EBITDA
- 1.54x
- EV / EBIT
- 0.70x
- Market cap
- $36.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026